← Back
Data updated: Mar 10, 2026
TERSERA
Oncology
TERSERA is a specialty pharmaceutical company focused on Oncology. Key products include VARUBI.
1989
Since
5
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...